<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3686">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03058926</url>
  </required_header>
  <id_info>
    <org_study_id>PA16-0439</org_study_id>
    <secondary_id>1U01DK108328-01</secondary_id>
    <nct_id>NCT03058926</nct_id>
  </id_info>
  <brief_title>Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer</brief_title>
  <official_title>Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The data management systems, auditing, and monitoring effort are supported by the MD
      Anderson Cancer Center Clinical Research Support Center (CRSC). The The Coordination and
      Data Management Center (CDMC) will provide high quality, efficient and consistent leadership
      and services in all aspects of data quality and assurance; data harmonization and
      management; while providing assistance to the projects in disseminating and interpreting
      those data. The CDMC PI will provide statistical (study design, analysis plans, data
      analysis, and interpretation), data management, and data monitoring/auditing (data quality
      assurance and harmonization) expertise for the proposed projects. The Cancer Center will
      have access to identifiable data from studies; analysis of this data will not be conducted
      under this protocol. Any future analysis conducted on data or specimens as part of CPDPC
      protocols will be conducted under a separate IRB approved data or lab protocol.

      The CDMC will leverage existing support, infrastructure, and resources from the Data
      Management and Coordinating Center for the Global Cancer Early Detection and the clinical
      expertise of the Division of Pathology/Lab Medicine at MDACC.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 19, 2017</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Protocol and Regulatory Compliance for Consortium Studies for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)</measure>
    <time_frame>3 years</time_frame>
    <description>Clinical Research Support Center's Data Management and Multicenter Study Support (MCSS) will monitor data quality and protocol compliance at all participating institutions.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">25000</enrollment>
  <condition>Chronic Pancreatitis</condition>
  <condition>Diabetes</condition>
  <condition>Pancreatic Cancer</condition>
  <arm_group>
    <arm_group_label>Chronic Pancreatitis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetes</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pancreatic Cancer</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data Management and Monitoring</intervention_name>
    <description>Clinical Research Support Center's Data Management and Multicenter Study Support (MCSS) teams responsible for monitoring protocol and regulatory compliance for all consortium studies.
MCSS responsible for maintaining and tracking IRB approval and regulatory documents from each site throughout the life of the study.</description>
    <arm_group_label>Chronic Pancreatitis</arm_group_label>
    <arm_group_label>Diabetes</arm_group_label>
    <arm_group_label>Pancreatic Cancer</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and urine examined for biomarker evaluation.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants recruited from external sites.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants with chronic pancreatis, diabetes, and pancreatic cancer recruited
             through Consortium.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ziding Feng, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ziding Feng, PHD</last_name>
    <phone>713-563-4276</phone>
  </overall_contact>
  <location>
    <facility>
      <name>University of Texas MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>University of Texas MD Anderson Cancer Center Website</description>
  </link>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 16, 2017</lastchanged_date>
  <firstreceived_date>February 15, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Pancreatitis</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Pancreatic Cancer</keyword>
  <keyword>Data Management</keyword>
  <keyword>Protocol compliance</keyword>
  <keyword>Regulatory compliance</keyword>
  <keyword>Consortium studies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Pancreatitis, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
